Press Release
July 14, 2021
Funding will advance Entos’ breakthrough AI and quantum mechanics-driven drug design platform. Opens new San Diego headquarters with state-of-the-art laboratory.
Unitary N-body tensor equivariant network with applications to quantum chemistry
Jack Taunton and Ken Brameld join Entos scientific advisory board
A machine learning potential for biological and organic chemistry with semi-empirical cost and DFT accuracy
Envision: Interactive quantum chemistry free for academic and educational users
Tim brings unparalleled expertise in drug discovery, synthetic optimization, and data science
Entos selected by Forbes Magazine for 2022 list of groundbreaking artificial intelligence companies
Nick brings 35 years of R&D experience across a broad spectrum of therapeutic areas and modalities
A statement from the Entos management team and Board of directors in memoriam of Naren Gupta
Nine Entos Team members among the #COVIDisAirborne team that is selected as Gordon Bell Finalists and featured in The New York Times
NVIDIA Clara Discovery is powering the San Diego startup’s new machine learning approach for developing next-generation therapeutics
Polyolefin production enabled by quantum machine learning
Sarah brings a wealth of experience in pharma, synthesis, and discovery software
New partnership to create innovative platform for research and education
AI-Enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol
Refine the OrbNet model to accurately predict energy, forces, and other response properties
Deep learning for quantum chemistry using symmetry-adapted atomic-orbital features
